# Aldeyra Therapeutics (ALDX) — News

ALDX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/aldx/news

## Recent headlines

- [Payward-Saldo deal seen closing in 2027](https://www.ainvest.com/news/payward-saldo-deal-closing-2027-2610) — AInvest Wire, Oct 14, 2026
  The anticipated merger between Payward and Saldo, two prominent players in the digital payments sector, is expected to finalize in 2027, according to recent regulatory filings and internal communications from both companies. The deal, which has been under review by antitrust authorities since early…
- [Aldeyra Therapeutics - FDRR to appeal March 16, 2026 complete response letter denying NDA for Reproxalap](https://www.ainvest.com/news/aldeyra-therapeutics-fdrr-appeal-march-16-2026-complete-response-letter-denying-nda-reproxalap-2609) — AInvest Wire, Sep 29, 2026
- [Aldeyra Therapeutics - To submit formal dispute resolution request to FDA for Reproxalap](https://www.ainvest.com/news/aldeyra-therapeutics-submit-formal-dispute-resolution-request-fda-reproxalap-2609) — AInvest Wire, Sep 29, 2026
- [Aldeyra extends cash runway into 2029 on $45.1M reserves](https://www.ainvest.com/news/aldeyra-extends-cash-runway-2029-45-1m-reserves-2609) — AInvest Wire, Sep 29, 2026
- [Aldeyra to meet FDA office of new drugs in 4Q 2026](https://www.ainvest.com/news/aldeyra-meet-fda-office-drugs-4q-2026-2609) — AInvest Wire, Sep 29, 2026
  Aldeyra Therapeutics has announced plans to meet with the U.S. Food and Drug Administration’s Office of New Drugs in the fourth quarter of 2026. The meeting is intended to discuss the company’s ongoing drug development programs and regulatory pathways for its therapeutic candidates. While specific…

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).